Journal
SHOCK
Volume 20, Issue 5, Pages 386-401Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/01.SHK.0000092698.10326.6f
Keywords
SIRS; CARS; gene therapy; lymphocyte; T-cell apoptosis
Funding
- NIGMS NIH HHS [T32 GM-08721-03, R37 GM-40586, R01 GM-63212] Funding Source: Medline
Ask authors/readers for more resources
Sepsis is a syndrome of significant morbidity and mortality. Unlike the advances made in other diseases processes, improvements in outcome from sepsis, severe sepsis, and septic shock have been modest. Current research has altered our understanding of sepsis pathogenesis such that present models and definitions are still evolving. One relatively novel cell type, the dendritic cell, is the subject of much current investigation in sepsis. Although our present understanding of dendritic cell biology is incomplete, growing evidence supports the importance of this antigen-presenting cell in the normal and maladaptive responses to microbial invasion and tissue injury. A better understanding of this cell's basic biology as well as its potential as a therapeutic target will undoubtedly play increasing roles in the development of new strategies for the treatment of the septic patient.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available